featured
June 2026
July 2026
September 2026
Tuesday, June 9, 2026, 1:00–2:00 PM ET
In this webinar, we will examine how immune recognition after allogeneic HCT can influence leukemia relapse and disease progression. The session will highlight the clinical relevance of HLA loss of heterozygosity (LOH), approaches used for its detection, and how LOH findings may support transplant strategies, including considerations for donor selection in subsequent transplantation.
Webinar presenter Alberto Cardoso Martins Lima, PhD, Clinical consulting scientist in histocompatibility,
specializing in allogeneic hematopoietic cell transplantation (HCT) at IGEN/AFIP São Paulo and CHC/UFPR in Curitiba, Brazil
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenter Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, July 15, 2026, 1:00-2:00 PM ET
Hear an expert discuss how to integrate Kappa and Lambda in situ hybridization testing into your standard hematopathology workflow to accurately assess B-cell and plasma cell clonality. You will also gain the skills to recognize testing pitfalls in challenging reactive versus neoplastic proliferations and apply ancillary tools to resolve complex cases.
Webinar presenter Xiaojun Wu, MD, PhD, Assistant professor, Director of Hematopathology Section at NCR of Johns Hopkins Medicine Department of Pathology, SOM at Johns Hopkins University
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
June 2026
Medical and surgical gender-affirmation therapies for transgender people have introduced a new spectrum to pathology practices. Sex hormones influence both anatomic and clinical pathology, which can complicate result interpretation for
Medical and surgical gender-affirmation therapies for transgender people have introduced a new spectrum to pathology practices. Sex hormones influence both anatomic and clinical pathology, which can complicate result interpretation for surgical specimens, chemistry, hematology, and microbiology. This activity provides tools to help you successfully serve the transgender population and address the needs of your clinical colleagues in this regard.
This activity was originally presented at CAP23 as part of the activity Anatomic and Clinical Pathology Needs in Transgender Care.
Online course was released on 3/4/2024 and will end on 3/3/2027.
Are your transfusion guidelines up to date? Can you cope with a critical RBC or platelet shortage? This activity succinctly synthesizes current multidisciplinary transfusion practice recommendations for all blood components
Are your transfusion guidelines up to date? Can you cope with a critical RBC or platelet shortage? This activity succinctly synthesizes current multidisciplinary transfusion practice recommendations for all blood components into a logical framework applicable to peer education, blood management programs, and electronic guidance for blood ordering. Included within this activity is a presentation of actual live participants using audience response technology to share benchmarking information on their hospital’s current practices. In addition, you will learn how they can apply up-to-date guidelines to everyday patient problems. Using this foundation, next steps to prepare for and mitigate potential blood shortages are discussed.
This activity was originally presented at CAP23 as part of the activity Can You Bank on Your Blood Supply: Using Blood Wisely and in Shortages.
Online course was released on 3/4/2024 and will end on 3/3/2027.
Direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, arrived on the market with no need for monitoring. As the use of DOACs expand, it is becoming clearer that their
Direct oral anticoagulants (DOACs), such as apixaban and rivaroxaban, arrived on the market with no need for monitoring. As the use of DOACs expand, it is becoming clearer that their measurement may be necessary in specific situations, and more institutions are integrating either qualitative or quantitative assays. To help you stay abreast of current medical thought, use cases and audience polling examples are included to illustrate and prepare for new testing. Additionally, this activity addresses questions such as: Which type of assay is most appropriate for your institution? How do you validate these assays, many of which are not FDA-cleared? When should they be used? How do you integrate the testing in the ordering menu for clinicians?
This activity was originally presented at CAP23 as part of the activity Optimize or Implement Lab Testing for Xa-Inhibitory Direct Oral Anticoagulant (DOAC) Detection.
The Lodge at Torrey Pines — La Jolla, California
July 2026
Eau Palm Beach Resort — Palm Beach, FL
Fairmont Orchid, Kohala Coast, Big Island of Hawaii
1 North Kaniku Drive
Pathology in the Park at Disney’s BoardWalk Inn will bring you the perfect mix of education and escape. You’ll balance your days

Pathology in the Park at Disney’s BoardWalk Inn will bring you the perfect mix of education and escape. You’ll balance your days between education sessions—featuring top faculty in GI, pancreas, and hematopathology—and time with family and friends at the parks or pool.
Registration includes an exclusive VIP reception for you and three guests at Italy Isola in Epcot, the perfect spot to enjoy delicious bites, great company, and a front-row view of the Epcot Nighttime Spectacular!
Learn, connect, and recharge, July 15–17, 2026. Pathology in the Park is where professional growth meets unforgettable experiences.
*Book your spot today.
*A minimum number of registrants is required for this course.
Disney's BoardWalk Inn
Orlando, Florida
September 2026
Semmelweis University
H-1085 Budapest, Üllői út 26